Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
mercoledì, ottobre 28
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
P3 Health Partners Inc
PIII
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$4.14
0.33
8.66%
Ult. Agg.: Oct 28, 12:12 PM
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Rapporto azionario
Utili:
I risultati di Q3 2026 tra 12 giorni da adesso in lun nov 9th, dopo la chiusura del mercato
P3 Health Partners Financials
P3 Health Partners (PIII) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
P3 Health Partners Q2 EPS $(0.63) Beats $(1.90) Estimate, Sales $386.381M Beat $377.950M Estimate
Benzinga Newsdesk
PRO
P3 Health Partners Narrows FY2026 Sales Guidance from $1.500B-$1.650B to $1.500B-$1.600B vs $1.524B Est
P3 Health Partners (NASDAQ:PIII) narrows FY2026 sales outlook from $1.500 billion-$1.650 billion to $1.500 billion-$1.600 billion vs $1.524 billion estimate.
Benzinga Newsdesk
P3 Health Partners (PIII) Stock Surges Over 42% After Hours: Here's Why
P3 Health Partners Inc. shares surged 42.68% in after-hours trading after reporting first-quarter 2026 results that showed a narrower loss than expected.
Mohd Haider
PRO
P3 Health Partners Narrows FY2026 Sales Guidance from $1.500B-$1.700B to $1.500B-$1.650B vs $1.539B Est
P3 Health Partners (NASDAQ:PIII) narrows FY2026 sales outlook from $1.500 billion-$1.700 billion to $1.500 billion-$1.650 billion vs $1.539 billion estimate.
Benzinga Newsdesk
PRO
P3 Health Partners Q1 EPS $(1.72) Beats $(3.28) Estimate, Sales $386.390M Miss $391.500M Estimate
P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(1.72) per share which beat the analyst consensus estimate of $(3.28) by 47.56 percent. This is a 72.61 percent increase over losses of $(6.28) per share
Benzinga Newsdesk
Earnings Scheduled For May 14, 2026
Benzinga Insights
